skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 105  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: New Records: New From Last Week remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor
Material Type:
Article
Add to My Research

Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor

Scientific reports, 2024-05, Vol.14 (1), p.11323-11323 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-61808-7 ;PMID: 38760468

Full text available

2
Blood DNA methylation signature of diet quality and association with cardiometabolic traits
Material Type:
Article
Add to My Research

Blood DNA methylation signature of diet quality and association with cardiometabolic traits

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 2047-4873 ;EISSN: 2047-4881 ;DOI: 10.1093/eurjpc/zwad317

Digital Resources/Online E-Resources

3
Rethinking health policy: life expectancy and mortality in an era of polycrisis
Material Type:
Article
Add to My Research

Rethinking health policy: life expectancy and mortality in an era of polycrisis

The Lancet (British edition), 2024-05, Vol.403 (10440), p.1956-1958 [Peer Reviewed Journal]

2024. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00754-2 ;PMID: 38762310

Full text available

4
Circulating citric acid cycle metabolites and risk of cardiovascular disease in the PREDIMED study
Material Type:
Article
Add to My Research

Circulating citric acid cycle metabolites and risk of cardiovascular disease in the PREDIMED study

2023 The Author(s). Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 0939-4753 ;EISSN: 1590-3729 ;DOI: 10.1016/j.numecd.2023.01.002

Digital Resources/Online E-Resources

5
903 Cardiovascular risk management in cutaneous and cutaneous with systemic lupus erythematosus
Material Type:
Article
Add to My Research

903 Cardiovascular risk management in cutaneous and cutaneous with systemic lupus erythematosus

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A73-A75 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.65

Full text available

6
904 Left ventricular dysfunction and inflammatory markers in systemic lupus erythematosus (SLE) patients with and without coronary microvascular dysfunction
Material Type:
Article
Add to My Research

904 Left ventricular dysfunction and inflammatory markers in systemic lupus erythematosus (SLE) patients with and without coronary microvascular dysfunction

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A76-A78 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.66

Full text available

7
New Hope for a Common and Deadly Heart Condition
Material Type:
Article
Add to My Research

New Hope for a Common and Deadly Heart Condition

The New England journal of medicine, 2024-05, Vol.390 (19) [Peer Reviewed Journal]

Copyright © 2024 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2400702

Full text available

8
Modelled impact of virtual fractional flow reserve in patients undergoing coronary angiography (VIRTU-4)
Material Type:
Article
Add to My Research

Modelled impact of virtual fractional flow reserve in patients undergoing coronary angiography (VIRTU-4)

Heart (British Cardiac Society), 2024-05, p.heartjnl-2024-324039 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2024-324039 ;PMID: 38754969

Full text available

9
Cardiac Rehabilitation - Challenges and Advances
Material Type:
Article
Add to My Research

Cardiac Rehabilitation - Challenges and Advances

The New England journal of medicine, 2024-05, Vol.390 (19), p.1834-1835 [Peer Reviewed Journal]

Copyright © 2024 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2403909 ;PMID: 38749050

Full text available

10
Cardiovascular risk among community members in three communities in the Cape Metropole of the Western Cape
Material Type:
Article
Add to My Research

Cardiovascular risk among community members in three communities in the Cape Metropole of the Western Cape

African journal of primary health care & family medicine, 2024-01, Vol.16 (1) [Peer Reviewed Journal]

2024. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2071-2928 ;EISSN: 2071-2936 ;DOI: 10.4102/phcfm.v16i1.4246

Full text available

11
Effects of nordic walking training on gait and exercise tolerance in male ischemic heart disease patients
Material Type:
Article
Add to My Research

Effects of nordic walking training on gait and exercise tolerance in male ischemic heart disease patients

Scientific reports, 2024-05, Vol.14 (1), p.11249-11249 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-62109-9 ;PMID: 38755348

Full text available

12
Effectiveness of community-based diabetes and hypertension prevention and management programmes in Indonesia and Viet Nam: a quasi-experimental study
Material Type:
Article
Add to My Research

Effectiveness of community-based diabetes and hypertension prevention and management programmes in Indonesia and Viet Nam: a quasi-experimental study

BMJ global health, 2024-05, Vol.9 (5) [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2059-7908 ;DOI: 10.1136/bmjgh-2024-015053

Full text available

13
Endocardial HDAC3 is required for myocardial trabeculation
Material Type:
Article
Add to My Research

Endocardial HDAC3 is required for myocardial trabeculation

Nature communications, 2024-05, Vol.15 (1), p.4166-4166 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-48362-6 ;PMID: 38755146

Full text available

14
621 Risk of damage progression with belimumab versus oral immunosuppressant use in patients with systemic lupus erythematosus
Material Type:
Article
Add to My Research

621 Risk of damage progression with belimumab versus oral immunosuppressant use in patients with systemic lupus erythematosus

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A56-A58 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.50

Full text available

15
Prognostic value of soluble AXL in serum from heart failure patients with preserved and reduced left ventricular ejection fraction
Material Type:
Article
Add to My Research

Prognostic value of soluble AXL in serum from heart failure patients with preserved and reduced left ventricular ejection fraction

2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). info:eu-repo/semantics/openAccess ;ISSN: 2075-4426 ;EISSN: 2075-4426 ;DOI: 10.3390/jpm13030446

Full text available

16
Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study
Material Type:
Article
Add to My Research

Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study

2023 Martín-Iguacel, Vazquez-Friol, Burgos, Bruguera, Reyes-Urueña, Moreno-Fornés, Aceitón, Díaz, Domingo, Saumoy, Knobel, Dalmau, Borjabad, Johansen, Miro, Casabona and Llibre. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 2296-858X ;EISSN: 2296-858X ;DOI: 10.3389/fmed.2023.1182359

Full text available

17
Effect of metformin use on graft and patient survival in kidney transplant recipients with type 2 diabetes: a systematic review protocol
Material Type:
Article
Add to My Research

Effect of metformin use on graft and patient survival in kidney transplant recipients with type 2 diabetes: a systematic review protocol

BMJ open, 2024-05, Vol.14 (5), p.e078393-e078393 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-078393 ;PMID: 38760033

Full text available

18
403 Trends in incidence and prevalence of atherosclerotic cardiovascular disease among patients with cutaneous lupus erythematosus from 2018–2020
Material Type:
Article
Add to My Research

403 Trends in incidence and prevalence of atherosclerotic cardiovascular disease among patients with cutaneous lupus erythematosus from 2018–2020

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A28-A31 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.26

Full text available

19
902 Effect of cumulative hydroxychloroquine dose on prevention of damage progression and major adverse cardiovascular events in patients with systemic lupus erythematosus
Material Type:
Article
Add to My Research

902 Effect of cumulative hydroxychloroquine dose on prevention of damage progression and major adverse cardiovascular events in patients with systemic lupus erythematosus

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A72-A73 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.64

Full text available

20
105 Non-traditional risk factors predict cardiovascular disease and contribute to disparities in a population-based cohort with systemic lupus erythematosus
Material Type:
Article
Add to My Research

105 Non-traditional risk factors predict cardiovascular disease and contribute to disparities in a population-based cohort with systemic lupus erythematosus

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A5-A8 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.5

Full text available

Results 1 - 20 of 105  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (82)

Refine My Results

Creation Date 

From To
  1. Before 2009  (1)
  2. 2009 To 2015  (1)
  3. 2016 To 2019  (1)
  4. 2020 To 2021  (3)
  5. After 2021  (100)
  6. More options open sub menu

Language 

  1. English  (99)
  2. Spanish  (3)
  3. Portuguese  (1)
  4. French  (1)
  5. Czech  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait